🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share comparison images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

According to TikTok, the service has taken down problematic content and banned associated hashtags and search suggestions. The company said it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Activities

Research also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, glowing testimonials and step-by-step guides for preparing or administering at home.

Within moments of entering one group, a seller posted WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Item Details and Pricing

Within these groups, posts show dark colored parcels with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her team has already encountered individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly significant health risks”.